TY - JOUR
T1 - Homeostasis and transitional activation of regulatory T cells require c-Myc
AU - Saravia, Jordy
AU - Zeng, Hu
AU - Dhungana, Yogesh
AU - Blanco, Daniel Bastardo
AU - Nguyen, Thanh Long M.
AU - Chapman, Nicole M.
AU - Wang, Yanyan
AU - Kanneganti, Apurva
AU - Liu, Shaofeng
AU - Raynor, Jana L.
AU - Vogel, Peter
AU - Neale, Geoffrey
AU - Carmeliet, Peter
AU - Chi, Hongbo
N1 - Funding Information:
We acknowledge D.R. Green and F.W. Alt for the Myc conditional allele, M. Hendren and A. KC for animal colony management, St. Jude Immunology FACS core facility for cell sorting, and S. A. Lim for help with the EAE animal model. Funding: This work was supported by the U.S. NIH (NIH AI105887, AI131703, AI140761, AI150241, AI150514, and CA221290 to H.C.).
Publisher Copyright:
Copyright © 2020 The Authors.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Regulatory T cell (Treg) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of Treg accumulation and functional activation. Myc activity is enriched in Tregs generated during neonatal life and responding to inflammation. Myc-deficient Tregs show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in Tregs results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4+ and CD8+ T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, Treg-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired Treg function and maturation. Thus, Myc coordinates Treg accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.
AB - Regulatory T cell (Treg) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of Treg accumulation and functional activation. Myc activity is enriched in Tregs generated during neonatal life and responding to inflammation. Myc-deficient Tregs show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in Tregs results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4+ and CD8+ T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, Treg-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired Treg function and maturation. Thus, Myc coordinates Treg accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=85077697151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077697151&partnerID=8YFLogxK
U2 - 10.1126/sciadv.aaw6443
DO - 10.1126/sciadv.aaw6443
M3 - Article
C2 - 31911938
AN - SCOPUS:85077697151
SN - 2375-2548
VL - 6
JO - Science advances
JF - Science advances
IS - 1
M1 - eaaw6443
ER -